Axsome Therapeutics, Inc. (AXSM) vs Bruker Corporation (BRKRP)
A side-by-side comparison of Axsome Therapeutics, Inc. and Bruker Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
AXSM
Axsome Therapeutics, Inc.
$175.62HealthcareDelayed quote: Oct 6, 2026, 9:30 AM EDT
BRKRP
Bruker Corporation
$466.08HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — AXSM vs BRKRP
growth of $100 · dividends reinvested · last 1yAXSM +42.3% (+42.3%/yr)BRKRP +94.8% (+94.8%/yr)BRKRP compounded faster over this window
AXSM BRKRP
AXSM vs BRKRP: by the numbers
- •BRKRP is the larger company ($9.35B vs $9.04B market cap).
- •Both run net losses; BRKRP's is the smaller (-2.03% vs -24.68% net margin).
- •BRKRP pays a dividend (3.35% yield), while AXSM has no payments in the available dividend history.
Metrics side by side
Valuation
| Metric | AXSM | BRKRP |
|---|---|---|
| Forward P/E | N/A | 219.64 |
| P/S ratio | 11.64 | 2.67 |
| P/B ratio | 108.49 | 3.90 |
| EV / EBITDA | N/A | 31.07 |
| FCF yield | N/A | 1.00% |
Profitability
| Metric | AXSM | BRKRP |
|---|---|---|
| Gross margin | 93.24% | 46.69% |
| Operating margin | -24.28% | 3.61% |
| Net margin | -24.68% | -2.03% |
| ROE | -230.05% | -2.97% |
| ROIC | -50.82% | 2.56% |
Dividends
| Metric | AXSM | BRKRP |
|---|---|---|
| Dividend yield | N/A | 3.35% |
Growth (annualized)
| Metric | AXSM | BRKRP |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 9.10% |
| FCF CAGR (5Y) | N/A | -21.33% |
| Total return CAGR (5Y) | 41.40% | N/A |
Frequently asked
- Does AXSM or BRKRP pay a bigger dividend?
- BRKRP pays a dividend (3.35% yield), while AXSM has no payments in the available dividend history.
Go deeper
Dig into the metrics
Bruker dividend yieldAxsome Therapeutics ROEBruker ROEAxsome Therapeutics operating marginBruker operating marginAxsome Therapeutics revenue growthBruker revenue growthAxsome Therapeutics free cash flowBruker free cash flow
Axsome Therapeutics & Bruker appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.